MIFH
WST icon

Migdal Insurance & Financial Holdings’s West Pharmaceutical WST Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-108
Closed -$24K – 454
2025
Q1 		$24K Buy
+108
New +$29.8K ﹤0.01% 340
2024
Q3 		– Sell
-18
Closed -$6K – 529
2024
Q2 		$6K Buy
+18
New +$6.36K ﹤0.01% 474
2021
Q2 		– Sell
-174
Closed -$49K – 682
2021
Q1 		$49K Buy
+174
New +$49.8K ﹤0.01% 551
2020
Q4 		– Sell
-5,977
Closed -$1.64M – 740
2020
Q3 		$1.64M Sell
5,977
-5,178
-46% -$1.37M 0.02% 218
2020
Q2 		$2.53M Buy
11,155
+3,639
+48% +$715K 0.04% 162
2020
Q1 		$1.14M Sell
7,516
-3,173
-30% -$488K 0.03% 159
2019
Q4 		$1.6M Buy
10,689
+1,483
+16% +$216K 0.03% 161
2019
Q3 		$1.3M Buy
9,206
+2,754
+43% +$379K 0.03% 215
2019
Q2 		$806K Buy
6,452
+1,871
+41% +$221K 0.02% 266
2019
Q1 		$504K Buy
+4,581
New +$476K 0.01% 299

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Migdal Insurance & Financial Holdings's WST Position: Q2 2025 in Review

Migdal Insurance & Financial Holdings sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 108 shares — an estimated $24K sold.

Migdal Insurance & Financial Holdings first reported a position in WST in Q1 2019 and held it in 10 quarters. The position peaked at $2.53M in Q2 2020. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Migdal Insurance & Financial Holdings reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 108 West Pharmaceutical shares in Q2 2025, an estimated $24K.
  • Migdal Insurance & Financial Holdings first reported a position in West Pharmaceutical in Q1 2019 and held it in 10 quarters.
  • Migdal Insurance & Financial Holdings's West Pharmaceutical position peaked at $2.53M in Q2 2020.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2025, filed 4 Aug 2025.